In comedy, the more you can surprise the audience by subverting their expectations, the better. There is nothing better than coming up with a brilliant set piece, something that writers and actors can ...

These bonafide classics remain as captivating as they were upon release nearly half a century later.

Beckoning audiences on a whimsical jaunt to always look on the bright side of life, the touring revival of “Spamalot” is especially winning for its unabashed determination to deliver on all manners of ...

From a $5m admission ticket to a national scandal, Michael Palin and Terry Gilliam reveal how the Pythons survived the chaotic making of a masterpiece.

Scientists may have spotted a long-sought triplet superconductor — a material that can transmit both electricity and electron spin with zero resistance. That ability could dramatically stabilize ...

Hello and welcome to Energy Source, coming to you from New York, where oil prices have surged above $70 following a report that Washington could take military action against Iran sooner than ...

Baker Bros. Advisors increased its stake in GRAIL by 455,208 shares during the fourth quarter; the estimated transaction value was $39.33 million based on quarterly average pricing. The quarter-end ...

GRAIL (GRAL) shares crashed on Thursday in reaction to a failure in a large U.K.-based clinical study for its Galleri multi-cancer screening test, which was added to the Hims & Hers (HIMS) telehealth ...

This article first appeared on GuruFocus. Grail (NASDAQ:GRAL) shares tumbled almost 50% on Friday after its three-year cancer screening trial missed its main goal, a setback for the blood test maker.

Investing.com -- Grail Inc (NASDAQ:GRAL) saw its stock tumble 30% in after-hours trading Thursday despite posting a narrower-than-expected quarterly loss. Investors appeared to focus on the biotech ...

In late 2020, physicist Harold “Sonny” White, PhD, research director of the nonprofit Limitless Space Institute, noticed something peculiar—and familiar—in a circular pattern of data plots generated ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...